Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Tramposch

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Biochemistry|November 21, 1995
Cooperativity and binding in the mechanism of cytosolic phospholipase A2J R Burke, M R Witmer, J Tredup, et al.
Biochemical and Biophysical Research Communications|November 30, 1992
Novel inhibitor of phospholipase A2 with topical anti-inflammatory activityK M Tramposch, S A Steiner, P L Stanley, et al.
Journal of Enzyme Inhibition|June 18, 1998
A beta-lactam inhibitor of cytosolic phospholipase A2 which acts in a competitive, reversible manner at the lipid/water interfaceJ R Burke, K R Gregor, R Padmanabha, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activityK M Tramposch, F H Chilton, P L Stanley, et al.
Bioorganic & Medicinal Chemistry|July 6, 2000
Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activityD M Springer, B Y Luh, J J Bronson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation modelsJ R Burke, L B Davern, P L Stanley, et al.
Journal of Medicinal Chemistry|November 5, 1997
Sulfated galactocerebrosides as potential antiinflammatory agentsA Marinier, A Martel, J Banville, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactionsG Todderud, X Nair, D Lee, et al.
The Journal of Biological Chemistry|June 26, 1999
Competitive, reversible inhibition of cytosolic phospholipase A2 at the lipid-water interface by choline derivatives that partially partition into the phospholipid bilayerJ R Burke, M R Witmer, F C Zusi, et al.
Bioorganic & Medicinal Chemistry|June 16, 2001
Novel mimics of sialyl Lewis X: design, synthesis and biological activity of a series of 2- and 3-malonate substituted galactoconjugatesA Marinier, A Martel, C Bachand, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Biochemistry|November 21, 1995
Cooperativity and binding in the mechanism of cytosolic phospholipase A2J R Burke, M R Witmer, J Tredup, et al.
Biochemical and Biophysical Research Communications|November 30, 1992
Novel inhibitor of phospholipase A2 with topical anti-inflammatory activityK M Tramposch, S A Steiner, P L Stanley, et al.
Journal of Enzyme Inhibition|June 18, 1998
A beta-lactam inhibitor of cytosolic phospholipase A2 which acts in a competitive, reversible manner at the lipid/water interfaceJ R Burke, K R Gregor, R Padmanabha, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activityK M Tramposch, F H Chilton, P L Stanley, et al.
Bioorganic & Medicinal Chemistry|July 6, 2000
Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activityD M Springer, B Y Luh, J J Bronson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation modelsJ R Burke, L B Davern, P L Stanley, et al.
Journal of Medicinal Chemistry|November 5, 1997
Sulfated galactocerebrosides as potential antiinflammatory agentsA Marinier, A Martel, J Banville, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactionsG Todderud, X Nair, D Lee, et al.
The Journal of Biological Chemistry|June 26, 1999
Competitive, reversible inhibition of cytosolic phospholipase A2 at the lipid-water interface by choline derivatives that partially partition into the phospholipid bilayerJ R Burke, M R Witmer, F C Zusi, et al.
Bioorganic & Medicinal Chemistry|June 16, 2001
Novel mimics of sialyl Lewis X: design, synthesis and biological activity of a series of 2- and 3-malonate substituted galactoconjugatesA Marinier, A Martel, C Bachand, et al.
Pageof 4